|
|
||||||||
Ann Thorac Surg 2001;71:S417-S421
© 2001 The Society of Thoracic Surgeons
a Heart Valve Therapy Research, Edwards Lifesciences, Irvine, California, USA
b UCLA Center for Health Sciences, Department of Pathology and Laboratory Medicine, Los Angeles, California, USA
Address reprint requests to Ms Cunanan, Edwards Lifesciences, Heart Valve Therapy Research, One Edwards Way, Irvine, CA 92614
e-mail: crystal_cunanan{at}edwards.com
Presented at the VIII International Symposium on Cardiac Bioprostheses, Cancun, Mexico, Nov 35, 2000.
Background. Tissue properties may contribute to intrinsic calcification of bioprosthetic heart valves. Phospholipids have been proposed as potential nucleation sites for calcification. Other tissue properties might also be important in calcification.
Methods. Commercial and control bioprosthetic valve tissues were characterized by shrinkage temperature, moisture content, free amine content, phospholipid content, and calcification level after 90-day rat subcutaneous implantation as described.
Results. Shrinkage temperature, moisture content, and free amine content were typical for glutaraldehydecross-linked tissues. Phospholipid and calcium levels varied considerably among valve types. There was a significant correlation between phospholipid levels and calcification (r = 0.63, p = 0.04). Sulzer Carbomedics Mitroflow and Toronto SPV valve tissues had significantly more calcification than other commercial bioprostheses in this study (p < 0.01). Carpentier-Edwards Duraflex, CE SAV, and CE PERIMOUNT valve tissues had significantly less calcification than Medtronic Mosaic in this animal model (p < 0.02).
Conclusions. Processes that reduce phospholipid levels are associated with reduced calcification in the rat subcutaneous model. Significant differences in calcification level were found among commercially available valves. The clinical significance of these results is unknown.
This article has been cited by other articles:
![]() |
S. H. Rahimtoola The year in valvular heart disease J. Am. Coll. Cardiol., January 4, 2005; 45(1): 111 - 122. [Full Text] [PDF] |
||||
![]() |
N. D. Desai, O. Merin, G. N. Cohen, J. Herman, S. Mobilos, J. Y. Sever, S. E. Fremes, B. S. Goldman, and G. T. Christakis Long-Term Results of Aortic Valve Replacement With the St. Jude Toronto Stentless Porcine Valve Ann. Thorac. Surg., December 1, 2004; 78(6): 2076 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bottio, G. Thiene, E. Pettenazzo, P. Ius, U. Bortolotti, G. Rizzoli, C. Valfre, D. Casarotto, and M. Valente Hancock II bioprosthesis: A glance at the microscope in mid-long-term explants J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 99 - 105. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |